NO20021502D0 - quinazolinones - Google Patents
quinazolinonesInfo
- Publication number
- NO20021502D0 NO20021502D0 NO20021502A NO20021502A NO20021502D0 NO 20021502 D0 NO20021502 D0 NO 20021502D0 NO 20021502 A NO20021502 A NO 20021502A NO 20021502 A NO20021502 A NO 20021502A NO 20021502 D0 NO20021502 D0 NO 20021502D0
- Authority
- NO
- Norway
- Prior art keywords
- quinazolinones
- Prior art date
Links
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40795899A | 1999-09-28 | 1999-09-28 | |
| PCT/EP2000/008940 WO2001023365A1 (en) | 1999-09-28 | 2000-09-13 | Quinazolinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20021502L NO20021502L (en) | 2002-03-26 |
| NO20021502D0 true NO20021502D0 (en) | 2002-03-26 |
Family
ID=23614261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20021502A NO20021502D0 (en) | 1999-09-28 | 2002-03-26 | quinazolinones |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1216235A1 (en) |
| KR (1) | KR20020047186A (en) |
| AR (1) | AR025797A1 (en) |
| AU (1) | AU7654800A (en) |
| BR (1) | BR0014294A (en) |
| CA (1) | CA2385921A1 (en) |
| NO (1) | NO20021502D0 (en) |
| WO (1) | WO2001023365A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| JP2005529076A (en) | 2002-02-15 | 2005-09-29 | サイトキネティクス・インコーポレーテッド | Synthesis of quinazolinone |
| AU2003223786A1 (en) | 2002-05-09 | 2003-11-11 | Cytokinetics, Inc. | Compounds, methods and compositions |
| WO2003097053A1 (en) | 2002-05-09 | 2003-11-27 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| AU2003265242A1 (en) | 2002-05-23 | 2003-12-22 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US7041676B2 (en) | 2002-06-14 | 2006-05-09 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| WO2003106435A1 (en) * | 2002-06-18 | 2003-12-24 | Sankyo Company, Limited | Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof |
| AU2003256805A1 (en) | 2002-07-23 | 2004-02-09 | Cytokinetics, Inc. | Compounds compositions and methods |
| US20040152696A1 (en) * | 2002-08-01 | 2004-08-05 | Euro-Celtique S.A. | 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| US7557115B2 (en) | 2002-09-30 | 2009-07-07 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| JP2006512315A (en) * | 2002-11-04 | 2006-04-13 | エヌピーエス ファーマスーティカルズ インコーポレイテッド | Quinazolinone compounds as calcilytics |
| EP1692112A4 (en) | 2003-12-08 | 2008-09-24 | Cytokinetics Inc | Compounds, compositions, and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670416A1 (en) * | 1966-12-30 | 1971-02-11 | Chem Fab Von Heyden Gmbh Muenc | Process for the preparation of amino-substituted quinazolinone derivatives |
| JPS6136273A (en) * | 1984-07-26 | 1986-02-20 | Mitsubishi Yuka Yakuhin Kk | 2-phenylalkyl-4(3h)-quinazolinone derivative |
| DE69521500T2 (en) * | 1994-03-08 | 2001-12-13 | Otsuka Pharmaceutical Factory, Inc. | PHOSPHORIC ACID DERIVATIVES |
| US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
-
2000
- 2000-09-13 KR KR1020027003907A patent/KR20020047186A/en not_active Withdrawn
- 2000-09-13 BR BR0014294-8A patent/BR0014294A/en not_active Application Discontinuation
- 2000-09-13 CA CA002385921A patent/CA2385921A1/en not_active Abandoned
- 2000-09-13 WO PCT/EP2000/008940 patent/WO2001023365A1/en not_active Ceased
- 2000-09-13 EP EP00965991A patent/EP1216235A1/en not_active Withdrawn
- 2000-09-13 AU AU76548/00A patent/AU7654800A/en not_active Abandoned
- 2000-09-27 AR ARP000105076A patent/AR025797A1/en unknown
-
2002
- 2002-03-26 NO NO20021502A patent/NO20021502D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001023365A1 (en) | 2001-04-05 |
| NO20021502L (en) | 2002-03-26 |
| KR20020047186A (en) | 2002-06-21 |
| EP1216235A1 (en) | 2002-06-26 |
| AR025797A1 (en) | 2002-12-11 |
| BR0014294A (en) | 2002-05-21 |
| AU7654800A (en) | 2001-04-30 |
| CA2385921A1 (en) | 2001-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID26447A (en) | ERITROPOIETIN DOWN | |
| DE19983871T1 (en) | Fönvorrichtung | |
| DE10084676T1 (en) | Einmallanzettvorrichtung | |
| DE50002834D1 (en) | handstamp | |
| ATE357433T1 (en) | 4-PYRIMIDINYL-N-ACYL-L-PHENYLANINE | |
| NO20021503D0 (en) | quinazolinones | |
| ATE297895T1 (en) | 4-PYRIDINYL-N-ACYL-L-PHENYLALANINE | |
| DE50007953D1 (en) | Beleuchtungsanordung | |
| NO20015290L (en) | Monofluoralkylderivater | |
| NO20021502D0 (en) | quinazolinones | |
| ID30214A (en) | RESORSINOL DOWN | |
| DE50008613D1 (en) | SICHERUNGSRING | |
| DE50000805D1 (en) | Aufsitzspanner | |
| DE50006899D1 (en) | ANTISTATIKUM | |
| DE10085008T1 (en) | Oberflächenbehandlungsdüse | |
| DE50003660D1 (en) | DIACYLHYDRAZINDERIVATE | |
| EP1156534A4 (en) | GALIUMPHOSPHID-LUMINESZENSBAUELEMENT | |
| DE50003259D1 (en) | TEXTILIE | |
| DE50006013D1 (en) | ANSCHLAGPUFFER | |
| DE19983890T1 (en) | Ventiltaktgebungsjustiereinrichtung | |
| DE50001640D1 (en) | NAHFELDOPTISCHE INTERSUCHUNGSVORRICHTUNG | |
| DE50008429D1 (en) | fuel- | |
| DE50006759D1 (en) | PIPERIDINALKOHOLE | |
| NO20020690L (en) | Injeksonsanordning | |
| ATE440824T1 (en) | NITRO-SULFOBENSAMIDE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |